Phase 1 First-in-human Study of JS014
Condition(s):Neoplasm Malignant; Neoplasm, Experimental; Solid Tumor, Adult; LymphomaLast Updated:November 23, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Neoplasm Malignant; Neoplasm, Experimental; Solid Tumor, Adult; LymphomaLast Updated:November 23, 2022Recruiting
Condition(s):Advanced Solid Tumor; Non-Hodgkin’s Lymphoma; Mantle Cell LymphomaLast Updated:May 31, 2023Recruiting
Condition(s):Advanced Solid TumorsLast Updated:April 5, 2022Completed
Condition(s):Advanced Stage Solid TumorsLast Updated:May 9, 2019Completed
Condition(s):Pancreatic DiseaseLast Updated:February 28, 2023Recruiting
Condition(s):End Stage Renal Disease; End Stage Renal Failure on DialysisLast Updated:October 10, 2022Active, not recruiting
Condition(s):SARS-CoV-2 (COVID-19)Last Updated:April 20, 2023Completed
Condition(s):Ulcerative ColitisLast Updated:May 6, 2023Completed
Condition(s):Advanced Solid Tumors; Sarcoma; Ewing Sarcoma; Dedifferentiated Liposarcoma; Synovial SarcomaLast Updated:December 13, 2022Recruiting
Condition(s):HealthyLast Updated:July 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.